Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Vector Science & Therapeutics Appoints Russell Starr as President

PRIVATEOct 14, 2026

Position

President

Company

Vector Science & Therapeutics

Russell Starr
DelawareBiotechnology

Description

Vector Science & Therapeutics Corp. has announced the appointment of Russell Starr as President, effective October 5, 2026. Starr, a seasoned entrepreneur and capital markets executive, will play a key role in driving the company's growth.

Company Information

Company

Vector Science & Therapeutics

Location

Delaware, United States

About

Vector Science & Therapeutics Corp. is an early-stage biotechnology company focused on developing and manufacturing pharma-grade peptides. They are advancing several innovative verticals aimed at driving revenue and profitability. The company operates under FDA license and adheres to cGMP standards for its manufacturing processes.

Fundz sees it the moment Vector Science & Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Barry
Senior decision-maker at this company
••••••••@••••••••

See Barry's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Vector Science & Therapeutics's next move

Learn about Strategic plan

Vector Science & Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.